Artivion Full Year 2024 Earnings: EPS Misses Expectations
Full Year 2024 Results Key Financial Results Revenue: US$388.5m (up 9.8% from FY 2023).
Hosted on MSN4d
Down -18.58% in 4 Weeks, Here's Why Artivion (AORT) Looks Ripe for a Turnaround
A downtrend has been apparent in Artivion (AORT) lately with too much selling pressure. The stock has declined 18.6% over the ...
2025 Biomaterials Global Market Overview, 2021-2030 - Collaborative Research And Smart Biomaterials Drive Industry Growth
This global report on Biomaterials analyzes the global and regional markets based on type and application for the period 2021-2030 with forecasts from 2024 to 2030 in terms of value in US$. In ...
Earnings Miss: Artivion, Inc. Missed EPS And Analysts Are Revising Their Forecasts
It's been a mediocre week for Artivion, Inc. ( NYSE:AORT ) shareholders, with the stock dropping 13% to US$25.42 in ...
Artivion (NYSE:AORT) Shares Gap Down on Disappointing Earnings
Artivion, Inc. (NYSE:AORT – Get Free Report)’s stock price gapped down before the market opened on Tuesday following a dissappointing earnings announcement. The stock had previously closed at $27.85, ...
Stifel Nicolaus Lowers Artivion (NYSE:AORT) Price Target to $30.00
Artivion (NYSE:AORT – Get Free Report) had its target price reduced by equities research analysts at Stifel Nicolaus from $33 ...
Artivion (AORT) Stock Trades Down, Here Is Why
Shares of medical device company Artivion (NYSE:AORT) fell 11.2% in the morning session after the company reported weak fourth-quarter 2024 results, as both revenue and EPS missed Wall Street's ...
Artivion, Inc. (NYSE:AORT) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 24, 2025 Artivion, Inc. misses on earnings expectations. Reported EPS is $-0.39 EPS ...